We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+11.63%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$3.6B
AUM Growth
+$334M
(+10%)
Cap. Flow
-$6.81M
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
178
New
20
Increased
59
Reduced
61
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$37.7M |
| 2 |
SBNY
Signature Bank
SBNY
|
+$34.1M |
| 3 |
Hormel Foods
HRL
|
+$27M |
| 4 |
IPG Photonics
IPGP
|
+$14.8M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$30.4M |
| 2 |
Aptiv
APTV
|
+$24.8M |
| 3 |
Johnson & Johnson
JNJ
|
+$16.1M |
| 4 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$14.7M |
| 5 |
Baidu
BIDU
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.75% |
| 2 | Technology | 15.47% |
| 3 | Financials | 14.79% |
| 4 | Communication Services | 14.34% |
| 5 | Healthcare | 13.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZLTQ
151
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $1.45M | 0.04% |
26,000
-294,100
| -92% | -$14.7M |
|
152
Prothena Corp
PRTA
$475M
| $1.4M | 0.04% |
25,000
+6,000
| +32% | +$315K |
|
153
Wynn Resorts
WYNN
$10.6B
| $1.38M | 0.04% |
+12,000
| New | +$1.2M |
|
154
First Solar
FSLR
$24.4B
| $1.34M | 0.04% |
49,496
+21,496
| +77% | +$705K |
|
|
CVA
155
DELISTED
Covanta Holding Corporation
CVA
| $1.31M | 0.04% |
83,424
+16,024
| +24% | +$252K |
|
|
SAGE
156
DELISTED
Sage Therapeutics
SAGE
| $1.28M | 0.04% |
+18,000
| New | +$1.05M |
|
157
Agios Pharmaceuticals
AGIO
$2.04B
| $1.17M | 0.03% |
+20,000
| New | +$959K |
|
|
TSRO
158
DELISTED
TESARO, Inc.
TSRO
| $1.08M | 0.03% |
7,000
-22,000
| -76% | -$3.58M |
|
159
Coherus Oncology
CHRS
$181M
| $952K | 0.03% |
45,000
| – | – |
|
160
DexCom
DXCM
$34.3B
| $847K | 0.02% |
+40,000
| New | +$781K |
|
161
iShares MSCI Brazil Small-Cap ETF
EWZS
$209M
| $805K | 0.02% |
+59,000
| New | +$787K |
|
162
Incyte
INCY
$24.5B
| $802K | 0.02% |
+6,000
| New | +$764K |
|
163
Minerva Neurosciences
NERV
$187M
| $770K | 0.02% |
11,875
+3,125
| +36% | +$243K |
|
164
Weibo
WB
$1.91B
| $731K | 0.02% |
+14,000
| New | +$697K |
|
|
HIND
165
Vyome Holdings
HIND
$15.6M
| – | – |
0
| – | – |
|
166
iShares US Regional Banks ETF
IAT
$687M
| $448K | 0.01% |
+10,000
| New | +$462K |
|
167
Huazhu Hotels Group
HTHT
$12.7B
| $372K | 0.01% |
+24,000
| New | +$336K |
|
|
CASC
168
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $348K | 0.01% |
84,000
| – | – |
|
169
Biogen
BIIB
$30.9B
| – | – |
-4,800
| Closed | -$1.36M |
|
170
Canadian Solar
CSIQ
$1.07B
| – | – |
-28,600
| Closed | -$348K |
|
171
eBay
EBAY
$45.5B
| – | – |
-80,000
| Closed | -$2.38M |
|
172
Edwards Lifesciences
EW
$53.6B
| – | – |
-85,500
| Closed | -$2.67M |
|
173
Exponent
EXPO
$3.22B
| – | – |
-222,000
| Closed | -$6.69M |
|
174
Huron Consulting
HURN
$2.39B
| – | – |
-169,500
| Closed | -$8.59M |
|
175
Regeneron Pharmaceuticals
REGN
$82.2B
| – | – |
-2,000
| Closed | -$734K |
|
Similar funds
VIA
Handelsbanken Fonder's Q1 2017 Portfolio in Review
As of Q1 2017, Handelsbanken Fonder held 178 positions worth $3.6B, up 10% from $3.27B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Handelsbanken Fonder's Q1 2017 filing shows 20 new, 59 increased, 61 reduced and 10 closed positions. Its largest new stake was Hormel Foods: 757,500 shares worth $26.2M. The largest sale was Colgate-Palmolive, an estimated $30.4M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Handelsbanken Fonder's largest Q1 2017 buy was Hormel Foods: 757,500 shares worth $26.2M.
- Handelsbanken Fonder added most to Alibaba in Q1 2017, an estimated $37.7M increase.
- Handelsbanken Fonder's biggest Q1 2017 reduction was Colgate-Palmolive, cutting an estimated $30.4M.
- Handelsbanken Fonder fully exited Huron Consulting in Q1 2017, selling an estimated $8.59M.
- Handelsbanken Fonder's ten largest holdings make up 25% of its $3.6B portfolio in Q1 2017.
- Handelsbanken Fonder opened 20 new positions and closed 10 in Q1 2017.
- Handelsbanken Fonder's portfolio value rose 10% quarter-over-quarter to $3.6B.
Based on Handelsbanken Fonder's 13F filing for Q1 2017, filed 4 May 2017.